Document Detail


Carglumic acid: a second look. Confirmed progress in a rare urea cycle disorder.
MedLine Citation:
PMID:  18516804     Owner:  HSR     Status:  MEDLINE    
Abstract/OtherAbstract:
(1) N-acetylglutamate synthase deficiency is a rare congenital disorder that causes hyperammonaemic comas, resulting in severe neurological morbidity and usually leading to death during childhood. (2) Carglumic acid is the first drug to be used for replacement therapy. Data available in 2003 showed beneficial effects on growth and psychomotor development. (3) In 2007, about 20 patients treated with carglumic acid for N-acetyglutamate synthase deficiency, for at least 5 years in half of cases, were all still alive. Their development was normal when treatment was initiated before complications occurred. (4) No serious adverse effects have been observed. (5) In practice, although this treatment has to continue for life, carglumic acid represents a major advance for patients with N-acetylglutamate synthase deficiency.
Authors:
-
Related Documents :
15699064 - Radial transport of water and abscisic acid (aba) in roots of zea mays under conditions...
4729974 - Fat absorption in essential fatty acid deficiency: a model experimental approach to stu...
9560034 - Essential fatty acid metabolism in infants with cholestasis.
11224654 - Directed modification instead of normalization of fatty acid patterns in cystic fibrosi...
7887924 - Elucidation of antioxidant activity of alpha-lipoic acid toward hydroxyl radical.
12586404 - Vacuolar system of ungerminated colletotrichum graminicola conidia: convergence of auto...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prescrire international     Volume:  17     ISSN:  1167-7422     ISO Abbreviation:  Prescrire Int     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-06-02     Completed Date:  2008-06-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9439295     Medline TA:  Prescrire Int     Country:  France    
Other Details:
Languages:  eng     Pagination:  50-1     Citation Subset:  T    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Amino-Acid N-Acetyltransferase / deficiency*
Child
Child, Preschool
Clinical Trials as Topic
Europe
Glutamates / administration & dosage,  adverse effects,  therapeutic use*
Humans
Hyperammonemia / drug therapy*,  etiology
Infant
Infant, Newborn
Metabolism, Inborn Errors / complications,  drug therapy*
Urea / metabolism
Chemical
Reg. No./Substance:
0/Glutamates; 57-13-6/Urea; EC 2.3.1.1/Amino-Acid N-Acetyltransferase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy.
Next Document:  0.4% glyceryl trinitrate ointment: new drug. Not useful for anal fissures.